325 related articles for article (PubMed ID: 27713887)
21. Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin.
Sozio E; Moore NA; Fabris M; Ripoli A; Rumbolo F; Minieri M; Boverio R; Rodríguez Mulero MD; Lainez-Martinez S; Martínez Martínez M; Calvo D; Gregoriano C; Williams R; Brazzi L; Terrinoni A; Callegari T; Hernández Olivo M; Esteban-Torrella P; Calcerrada I; Bernasconi L; Kidd SP; Sbrana F; Miguens I; Gordon K; Visentini D; Legramante JM; Bassi F; Cortes N; Montrucchio G; Di Lecce VN; Lauritano EC; García de Guadiana-Romualdo L; González Del Castillo J; Bernal-Morell E; Andaluz-Ojeda D; Schuetz P; Curcio F; Tascini C; Saeed K
Respir Res; 2022 Aug; 23(1):221. PubMed ID: 36031619
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.
Suberviola B; Castellanos-Ortega A; Llorca J; Ortiz F; Iglesias D; Prieto B
Swiss Med Wkly; 2012; 142():w13542. PubMed ID: 22430899
[TBL] [Abstract][Full Text] [Related]
23. Mid-regional pro-adrenomedullin predicts poor outcome in non-selected patients admitted to an intensive care unit.
Bellia C; Agnello L; Lo Sasso B; Bivona G; Raineri MS; Giarratano A; Ciaccio M
Clin Chem Lab Med; 2019 Mar; 57(4):549-555. PubMed ID: 30157027
[TBL] [Abstract][Full Text] [Related]
24. MR-proADM: A New Biomarker for Early Diagnosis of Sepsis in Burned Patients.
Gille J; Ostermann H; Dragu A; Sablotzki A
J Burn Care Res; 2017; 38(5):290-298. PubMed ID: 28221298
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of mid-regional proadrenomedullin levels in the resuscitation phase of severely burned patients and its utility in early sepsis detection.
Flores E; Estébanez B; Quintana M; Fernández-Puntero B; Nanwani K; Cachafeiro L; Martínez JR; Agrifoglio A; Sánchez-Sánchez M
Burns; 2024 Aug; 50(6):1519-1527. PubMed ID: 38570251
[TBL] [Abstract][Full Text] [Related]
26. Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS.
de Montmollin E; Peoc'h K; Marzouk M; Ruckly S; Wicky PH; Patrier J; Jaquet P; Sonneville R; Bouadma L; Timsit JF
Antibiotics (Basel); 2022 Aug; 11(9):. PubMed ID: 36139946
[TBL] [Abstract][Full Text] [Related]
27. Mr-Proadm Elevation Upon Icu Admission Predicts the Outcome of Septic Patients and is Correlated with Upcoming Fluid Overload.
Charles PE; Péju E; Dantec A; Bruyère R; Meunier-Beillard N; Dargent A; Prin S; Wilson D; Quenot JP
Shock; 2017 Oct; 48(4):418-426. PubMed ID: 28414691
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
Cinar O; Cevik E; Acar A; Kaya C; Ardic S; Comert B; Yokusoglu M; Bilgi C; Meisner M; Madsen T
Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
[TBL] [Abstract][Full Text] [Related]
29. The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial.
Elke G; Bloos F; Wilson DC; Brunkhorst FM; Briegel J; Reinhart K; Loeffler M; Kluge S; Nierhaus A; Jaschinski U; Moerer O; Weyland A; Meybohm P;
Crit Care; 2018 Mar; 22(1):79. PubMed ID: 29562917
[TBL] [Abstract][Full Text] [Related]
30. Does mid-regional pro-adrenomedullin (MR-proADM) improve the sequential organ failure assessment-score (SOFA score) for mortality-prediction in patients with acute infections? Results of a prospective observational study.
Haag E; Gregoriano C; Molitor A; Kloter M; Kutz A; Mueller B; Schuetz P
Clin Chem Lab Med; 2021 May; 59(6):1165-1176. PubMed ID: 33554514
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.
Enguix-Armada A; Escobar-Conesa R; García-De La Torre A; De La Torre-Prados MV
Clin Chem Lab Med; 2016 Jan; 54(1):163-8. PubMed ID: 26083268
[TBL] [Abstract][Full Text] [Related]
32. Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity.
Andaluz-Ojeda D; Nguyen HB; Meunier-Beillard N; Cicuéndez R; Quenot JP; Calvo D; Dargent A; Zarca E; Andrés C; Nogales L; Eiros JM; Tamayo E; Gandía F; Bermejo-Martín JF; Charles PE
Ann Intensive Care; 2017 Dec; 7(1):15. PubMed ID: 28185230
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic accuracy of mid-regional pro-adrenomedullin for sepsis: a systematic review and meta-analysis.
Li P; Wang C; Pang S
Minerva Anestesiol; 2021 Oct; 87(10):1117-1127. PubMed ID: 34134460
[TBL] [Abstract][Full Text] [Related]
34. Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure.
Spoto S; Argemi J; Di Costanzo R; Gavira Gomez JJ; Salterain Gonzales N; Basili S; Cangemi R; Abbate A; Locorriere L; Masini F; Testorio G; Calarco R; Battifoglia G; Mangiacapra F; Fogolari M; Costantino S; Angeletti S
J Pers Med; 2023 Jul; 13(7):. PubMed ID: 37511766
[TBL] [Abstract][Full Text] [Related]
35. Mid-regional pro-adrenomedullin as prognostic biomarker in septic shock.
DE LA Torre-Prados MV; Garcia-DE LA Torre A; Enguix A; Mayor-Reyes M; Nieto-González M; Garcia-Alcantara A
Minerva Anestesiol; 2016 Jul; 82(7):760-6. PubMed ID: 26967830
[TBL] [Abstract][Full Text] [Related]
36. Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis.
Angeletti S; Battistoni F; Fioravanti M; Bernardini S; Dicuonzo G
Clin Chem Lab Med; 2013 May; 51(5):1059-67. PubMed ID: 23072859
[TBL] [Abstract][Full Text] [Related]
37. Systematic review with meta-analysis of mid-regional pro-adrenomedullin (MR-proadm) as a prognostic marker in Covid-19-hospitalized patients.
Fialek B; De Roquetaillade C; Pruc M; Navolokina A; Chirico F; Ladny JR; Peacock FW; Szarpak L
Ann Med; 2023 Dec; 55(1):379-387. PubMed ID: 36607317
[TBL] [Abstract][Full Text] [Related]
38. Mid-regional pro-adrenomedullin in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.
Pervez MO; Lyngbakken MN; Myhre PL; Brynildsen J; Langsjøen EC; Høiseth AD; Christensen G; Omland T; Røsjø H
Clin Biochem; 2017 May; 50(7-8):394-400. PubMed ID: 28065681
[TBL] [Abstract][Full Text] [Related]
39. Mid-regional pro-adrenomedullin and lactate levels for risk stratification in patients with out-of-hospital cardiac arrest.
Zelniker TA; Schwall D; Hamidi F; Steinbach S; Scheller P; Spaich S; Michels G; Giannitsis E; Katus HA; Frey N; Preusch MR
Eur Heart J Acute Cardiovasc Care; 2023 Jun; 12(6):364-371. PubMed ID: 36943296
[TBL] [Abstract][Full Text] [Related]
40. Novel biomarkers in acute heart failure: MR-pro-adrenomedullin.
Peacock WF
Clin Chem Lab Med; 2014 Oct; 52(10):1433-5. PubMed ID: 24756062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
